Investigation of a Potential Shareholder Derivative Action Concerning MiMedx Group, Inc.
Kessler Topaz Meltzer & Check, LLP is investigating a potential shareholder derivative action on behalf of MiMedx Group, Inc. (“MiMedx”) (MDXG).
About MiMedx Group, Inc.
According to its website, MiMedx processes, markets, and distributes human amniotic tissue for use in therapeutic areas including ophthalmology, spine, chronic wounds, dental, orthopedic surgery, sports medicine, and urology.
Alleged Wrongful Conduct
Kessler Topaz Meltzer & Check, LLP is currently investigating whether the MiMedx’s Board of Directors breached its fiduciary duties to shareholders in connection with its failure to ensure that the company’s manufacturing and marketing of its core products were in compliance with regulations of the U.S. Food and Drug Administration.
If you currently own shares of MiMedx (MDXG), and would like to learn more about our investigation, please contact us today at 888-299-7706 or via email at info@ktmc.com.